What is hot at ESC 2023?
In this episode of View of the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) preview the hot line and late-breaking data presented at ESC Congress 2023. With their dynamic analysis, they place these highly anticipated trials within a context, highlighting the real-world implications tied to the data releases.
Top trials presented at ESC Congress 2023 include:
00:31: ECLS-SHOCK: Extracorporeal life support in cardiogenic shock
03:25: EARLY-UNLOAD: Early left ventricular unloading after extracorporeal membrane oxygenation
05:21: ARREST: Expedited transfer to a cardiac arrest center for OHCA
07:33: GUIDE-DES: QCA versus IVUS guidance for DES implantation
10:38: ILUMIEN IV: OCT versus angiography
13:11: OCTOBER: OCT-guided or angiography-guided PCI in complex bifurcation lesions
16:14: OCTIVUS: OCT- versus IVUS-guided PCI
18:27: FIRE: Functional versus culprit-only revascularization in elderly patients with myocardial Infarction and multivessel disease
19:50: OCT vs IVUS vs Angiography Guidance
20:11: Meta-analysis of iFR-SWEDEHEART and DEFINE FLAIR
20:53: HEART-FID: Ferric carboxymaltose in heart failure with iron deficiency
22:14: STOPDAPT-3: An aspirin-free antithrombotic strategy for percutaneous coronary intervention
24:50: MULTISTARTS AMI: Multivessel immediate versus staged revascularization in STEMI
26:20: NOTION: The nordic aortic valve intervention trial
Mark your calendar for our ESC Congress coverage starting August 25th. Interviews, discussions, and insights live from Amsterdam.
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Dr Irene Martin de Miguel (Hospital General Universitario Gregorio Marañón, Madrid, Spain) joins us in this featured author episode to outline her recent review article, Atrial Fibrillation in Congenital Heart Disease. In this podcast, Dr de Miguel provides an overview of the current knowledge of AF in CHD, giving practical recommendations for your everyday practice.
Today's episode features co-hosts Dr Peter Ong and Dr Andreas Seitz (Robert-Bosch Hospital, Stuttgart, DE) who together summarise the main results from the TARGET FFR and DEFINE-FLOW trials that were presented at TCT Connect 2020 and published recently in ECR journal, in the context of the existing literature.
Join renowned experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) as they preview the most impactful late-breaking studies poised to make waves at this year’s AHA Conference.
